Aric R. Sharp - 30 Jun 2024 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Signature
/s/ Peter J. Rivas, as attorney-in-fact for Aric Sharp
Issuer symbol
CLOV
Transactions as of
30 Jun 2024
Net transactions value
-$168,643
Form type
4
Filing time
02 Jul 2024, 16:12:29 UTC
Previous filing
13 May 2024
Next filing
13 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Award $0 +456,265 +26% $0.000000 2,244,741 30 Jun 2024 Direct F1
transaction CLOV Class A Common Stock Tax liability $168,643 -137,108 -6.1% $1.23 2,107,633 30 Jun 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on November 30, 2022. One-third of the number of earned restricted stock units vested and were settled on June 30, 2024, and the remaining 1/3 of the number of earned restricted stock units will vest on June 30, 2025, subject to the Reporting Person's continued employment on such vesting date.
F2 Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/3 of the number of earned restricted stock units, as described above.